SCHEMBL7835853

SCHEMBL7835853

CCN(CC)c1cc(NS(=O)(=O)c2ccc(N)cc2)ccn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 2/20 0.50
LMNA P02545 2/20 0.50
MAPT P10636 2/20 0.50
CYP2C9 P11712 1/20 0.50
DHFR P00374 1/20 0.50
TSHR P16473 1/20 0.50
HTR6 P50406 6/20 0.49
CDC7 O00311 1/20 0.48
EEF2K O00418 1/20 0.48
PLK4 O00444 1/20 0.48
DYRK3 O43781 1/20 0.48
RPS6KA5 O75582 1/20 0.48
PRKD3 O94806 1/20 0.48
MAP4K4 O95819 1/20 0.48
PIM1 P11309 1/20 0.48
PHKG2 P15735 1/20 0.48
CDK2 P24941 1/20 0.48
AKT1 P31749 1/20 0.48
AKT2 P31751 1/20 0.48
MAPK8 P45983 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1136475 0.85 HTR6 (0.52) AURKALMNAMAPTCYP2C9DHFR
Hydrochloric Acid SCHEMBL8043496 0.84 HTR6 (0.51) AURKALMNAMAPTCYP2C9DHFR
SCHEMBL8043494 0.80 CYP2C19 (0.60) AURKALMNAMAPTCYP2C9DHFR
Hydrochloric Acid SCHEMBL8056257 0.79 CYP2C19 (0.58) AURKALMNAMAPTCYP2C9DHFR
SCHEMBL7835318 0.76 HTR6 (0.72) AURKALMNAMAPTCYP2C9DHFR
SCHEMBL12903580 0.75 ALDH1A1 (0.70) LMNAMAPTTSHRHTR6ALDH1A1
SCHEMBL2176844 0.75 CYP2C19 (0.64) AURKALMNAMAPTCYP2C9DHFR
SCHEMBL7824897 0.72 HTR6 (0.62) AURKAMAPTCYP2C9HTR6CDC7
Hydrochloric Acid SCHEMBL8056242 0.71 ALDH1A1 (0.56) LMNAMAPTALDH1A1TDP1KMT2A
SCHEMBL11882161 0.71 ALDH1A1 (0.69) AURKALMNAMAPTDHFRTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0815861-B1 Sulphonamides and their use HOFFMANN LA ROCHE (CH) 2001-09-19 EP claimed
US-6030976-A SELECTIVE AFFINITY TO 5HT-6 RECEPTORS; CENTRAL NERVOUS SYSTEM DISORDERS; ALZHEIMER'S DISEASE, PSYCHOSES, SCHIZOPHRENIA, MANIC DEPRESSIONS, MEMORY DISORDERS, PARKINSON'S DISEASE, AMYOTROPHIC LATERAL SCLEROSIS AND HUNTINGTON'S DISEASE HOFFMAN-LA ROCHE INC. (US) 2000-02-29 US disclosed
US-5998665-A THERAPY FOR NERVOUS SYSTEM DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-12-07 US disclosed
US-5939451-A INDOL-4-YL-BENZENESULFONAMIDES AS ACTIVE MATERIAL TREATING MALARIA, BACTERIAL INFECTION, NEUROLOGICAL DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-08-17 US disclosed
US-5932599-A 4-AMINO-N-(PYRIDINYL-4-YL)-BENZENESULFONAMIDES AS ACTIVE MATERIAL TREATING MALARIA, BACTERIAL INFECTION, NEUROLOGICAL DISORDERS HOFFMANN-LA ROCHE INC. (US) 1999-08-03 US disclosed